We are in the business of identifying new and existing gaps and strengthening healthcare and life science by meeting them. Vertically integrated and globally recognised for our strength in research and development, manufacturing as also commercialisation of a wide range of products, we offer large-scale, quality and on-time delivery to our clients.
We deliver a diverse and expanding range of generics across chronic segments and have successfully introduced them to the domestic market, driving strong brand recall through our specialised marketing arm. The chronic segment has consistently grown, supported by customer loyalty, our expertise and brand value.
Strategic investments in the US-based R&D infrastructure
and manufacturing facilities help deliver rich dividends.
We are driving better health outcomes across the global
pharma industry, with an expanding portfolio and reach as
well as through valued partnerships.
Vertical integration into APIs has been our winning strategy. Capacity expansion
investments have helped create niche business streams and made us the preferred
manufacturer of select APIs.